Independent Director's 2025 Annual Work Report
Dear shareholders and shareholder representatives:
As an independent director of Lens Technology Co., Ltd. (hereinafter referred to as "the Company"), I hereby report on my performance of duties for the year 2025 in accordance with the "Administrative Measures for Independent Directors of Listed Companies" (hereinafter referred to as "the Measures") and other relevant regulations.
I. Basic Information
(1) Introduction of Wan Wei
Wan Wei: Female, born in 1972, Chinese nationality, no permanent residence abroad, associate professor, PhD. From 1994 to 2001, served at Hunan Province Pharmaceutical Health Products Import and Export Company. Since June 2004, has been a lecturer in marketing at Hunan University, currently serving as an associate professor in the Department of Marketing at the School of Business Administration and deputy director of the MBA Education Management Center. Since July 2021, has served as an independent director of the Company, primarily fulfilling the duties of an independent director and a member of the board's specialized committees.
(2) Independence Statement
In 2025, I did not hold any position in the Company other than that of independent director, nor did I hold any position in the Company's major shareholder's company. There are no interests or other relationships that may hinder my ability to perform my duties independently and objectively, in compliance with the requirements regarding the independence of independent directors as stipulated in the Measures and the "Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 2 - Standardized Operations of Growth Enterprise Market Listed Companies" (hereinafter referred to as "Standardized Operations").
II. Annual Performance Overview
(1) Attendance at Board and Shareholder Meetings
During the reporting period, the Company held a total of 10 board meetings, and I was required to attend all 10, with actual attendance being 10 times, with no proxy attendance or absences. The Company held 4 shareholder meetings, and I attended all 4. In reviewing the relevant proposals at each meeting, I carefully examined the proposals submitted to the board, maintained sufficient communication with the management, and made reasonable suggestions, exercising my voting rights with caution, thereby playing a positive role in the board's correct decision-making. I also attentively listened to the inquiries and suggestions from shareholders at the shareholder meetings. I believe that the convening and holding of the board and shareholder meetings in 2025 complied with legal requirements, and all relevant matters followed legal and effective decision-making procedures. Furthermore, none of the proposals discussed at the board meetings harmed the interests of the Company or its shareholders, thus I voted in favor of all proposals and raised no objections.
(2) Participation in Specialized Committee Work
- Nomination Committee Chair
During the reporting period, I served as the chair of the Company's fifth board's nomination committee, strictly fulfilling my responsibilities in accordance with the "Nomination Committee Work Rules" and relevant laws and regulations, attending and reviewing the first meeting of the fifth board's nomination committee regarding the proposal to determine the roles of the Company's directors. - Audit Committee Member
During the reporting period, I served as a member of the Company's fifth board's audit committee, strictly fulfilling my responsibilities in accordance with the "Audit Committee Work Rules" and relevant laws and regulations. The attendance at the relevant meetings of the fifth board's audit committee is as follows: